Try our beta test site
519 studies found for:    Open Studies | "Leukemia, Lymphoid"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Leukemia, Lymphoid"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting D-ALBA Frontline Sequential Dasatinib and Blinatumomab in Adult Philadelphia Positive Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: Dasatinib;   Drug: Blinatumomab
2 Recruiting B Cell Repertoires in Chronic Lymphocytic Leukemia and Aging
Condition: Chronic Lymphocytic Leukemia
Intervention:
3 Not yet recruiting Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents
Condition: Acute Lymphoblastic Leukemia, Pediatric
Interventions: Drug: Pegaspargase;   Drug: Erwinia asparaginase;   Drug: Cyclophosphamide;   Drug: CYTARABINE;   Drug: DASATINIB;   Drug: DEXAMETHASONE;   Drug: Dexrazoxane;   Drug: Doxorubicin;   Drug: ETOPOSIDE;   Drug: HYDROCORTISONE;   Drug: LEUCOVORIN CALCIUM;   Drug: MERCAPTOPURINE;   Drug: METHOTREXATE;   Drug: NELARABINE;   Drug: Vincristine
4 Recruiting A Study of Ibrutinib + Obinutuzumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Interventions: Drug: Obinutuzumab;   Drug: Ibrutinib
5 Recruiting CAR-T Therapy for Central Nervous System B-cell Acute Lymphocytic Leukemia
Condition: B-cell Acute Lymphocytic Leukemia
Intervention: Biological: CD19 CAR-T cells
6 Recruiting Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Condition: Acute Lymphoblastic Leukaemia
Interventions: Drug: VP16;   Radiation: TBI;   Drug: Thiotepa;   Drug: Treosulfan;   Drug: Fludarabine;   Drug: Busulfan
7 Recruiting Phase 1b Safety and Efficacy Study of TRU-016 and Rituximab, Obinutuzumab, Idelalisib, or Ibrutinib in Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Interventions: Biological: 20 mg/kg TRU-016 + Rituximab;   Biological: 10 mg/kg TRU-016 + Rituximab;   Biological: TRU-016 20 mg/kg + Obinutuzumab;   Biological: TRU-016 6-20 mg/kg + idelalisib + rituximab;   Biological: TRU-016 10-20 mg/kg + ibrutinib
8 Recruiting Treatment for Executive Dysfunction in Adult Survivors of Childhood Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Device: transcranial Direct Current Stimulation (tDCS);   Device: Sham;   Other: Cognitive Assessment;   Other: Brain Games Stimulation
9 Not yet recruiting Study of Low Dose Inotuzumab Ozogamicin in Patients With Relapsed and Refractory CD22 Positive Acute Lymphocytic Leukemia
Condition: Acute Lymphocytic Leukemia
Intervention: Drug: Inotuzumab ozogamicin
10 Recruiting Blinatumomab Maintenance Following Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: Blinatumomab;   Procedure: Hematopoietic Cell Transplantation
11 Recruiting Identification of Biomarkers That Are Predictive of Early Ibrutinib Treatment Failure in High Risk TP53 Mutated Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Intervention: Drug: Ibrutinib
12 Recruiting ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia Intermittent Versus Continuous PEG Asparaginase
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: PEG Asparaginase at six weeks interval;   Drug: PEG Asparaginase at two weeks interval
13 Recruiting Rituximab+mVPDL for CD20(+) Adult Acute Lymphoblastic Leukemia
Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma
Intervention: Drug: Rituximab+mVPDL
14 Recruiting informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia (CLL)
Intervention:
15 Recruiting A Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia (CLL) and Untreated CLL
Condition: Relapsed Chronic Lymphocytic Leukemia
Intervention: Drug: Metformin
16 Recruiting Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: ITMHA;   Drug: Dexamethasone;   Drug: Mitoxantrone;   Drug: Pegaspargase;   Drug: Asparaginase Erwinia Chrysanthemi;   Drug: Bortezomib;   Drug: Vorinostat;   Drug: Cyclophosphamide;   Drug: Mercaptopurine;   Drug: Methotrexate;   Drug: Leucovorin Calcium;   Drug: Cytarabine;   Drug: Etoposide;   Drug: Vincristine
17 Recruiting The GD-2008 ALL Protocol for Childhood Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: 6-mercaptopurine, Methotrexate;   Drug: 6-mercaptopurine, Methotrexate, Vincristine, Dexamethasone
18 Recruiting Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia L-asparaginase, Doxorubicin, Cyclophosphamide, Cytarabine, Thioguanine;   Drug: Clofarabine, Methotrexate, Mercaptopurine, Dexamethasone, Etoposide, Dasatinib
19 Recruiting Protocol For the Treatment Acute Lymphoblastic Leukemia With Ph 'Negative in Elderly Patients (> 55 Years)
Condition: Acute Lymphoblastic Leukemia
Intervention: Drug: Dexamethasona, Idarubicine, ARA-C, Methotrexate
20 Recruiting A French Protocol for the Treatment of Acute Lymphoblastic Leukemia (ALL) in Children and Adolescents
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: pegaspargase 1250 IU/m2 x 2;   Drug: pegaspargase 2500 IU/m2 x 1

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.